The long-term clinical course of acute deep venous thrombosis

被引:1638
作者
Prandoni, P
Lensing, AWA
Cogo, A
Cuppini, S
Villalta, S
Carta, M
Cattelan, AM
Polistena, P
Bernardi, E
Prins, MH
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT CLIN EPIDEMIOL & BIOSTAT, 1105 AZ AMSTERDAM, NETHERLANDS
[2] UNIV HOSP PADUA, PADUA, ITALY
关键词
thrombophlebitis; thromboembolism; blood coagulation disorders; recurrence; neoplasms;
D O I
10.7326/0003-4819-125-1-199607010-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In patients who have symptomatic deep venous thrombosis, the long-term risk for recurrent venous thromboembolism and the incidence and severity of post-thrombotic sequelae have not been well documented. Objective: To determine the clinical course of patients during the 8 years after their first episode of symptomatic deep venous thrombosis. Design: Prospective cohort study. Setting: University outpatient thrombosis clinic. Patients: 355 consecutive patients with a first episode of symptomatic deep venous thrombosis. Measurements: Recurrent venous thromboembolism, the post-thrombotic syndrome, and death. Potential risk factors for these outcomes were also evaluated. Results: The cumulative incidence of recurrent venous thromboembolism was 17.5% after 2 years of follow-up (95% CI, 13.6% to 22.2%), 24.6% after 5 years (CI, 19.6% to 29.7%), and 30.3% after 8 years (CI, 23.6% to 37.0%). The presence of cancer and of impaired coagulation inhibition increased the risk for recurrent venous thromboembolism (hazard ratios, 1.72 [CI, 1.31 to 2.25] and 1.44 [CI, 1.02 to 2.01], respectively). In contrast, surgery and recent trauma or fracture were associated with a decreased risk for recurrent venous thromboembolism (hazard ratios, 0.36 [CI, 0.21 to 0.62] and 0.51 [CI, 0.32 to 0.87], respectively). The cumulative incidence of the post-thrombotic syndrome was 22.8% after 2 years (CI, 18.0% to 27.5%), 28.0% after 5 years (CI, 22.7% to 33.3%), and 29.1% after 8 years (CI, 23.4% to 34.7%). The development of ipsilateral recurrent deep venous thrombosis was strongly associated with the risk for the post-thrombotic syndrome (hazard ratio, 6.4; CI, 3.1 to 13.3). Survival after 8 years was 70.2% (CI, 64.7% to 75.6%). The presence of cancer increased the risk for death (hazard ratio, 8.1; CI, 3.6 to 18.1). Conclusion: Patients with symptomatic deep venous thrombosis, especially those without transient risk factors for deep venous thrombosis, have a high risk for recurrent venous thromboembolism that persists for many years. The post-thrombotic syndrome occurs in almost one third of these patients and is strongly related to ipsilateral recurrent deep venous thrombosis. These findings challenge the widely adopted use of short-course anticoagulation therapy in patients with symptomatic deep venous thrombosis.
引用
收藏
页码:1 / +
页数:1
相关论文
共 27 条
[1]   A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
PATWARDHAN, NA ;
JOVANOVIC, B ;
FORCIER, A ;
DALEN, JE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938
[2]  
[Anonymous], 1994, HAEMOSTASIS
[3]  
[Anonymous], 1993, HEMOSTASIS THROMBOSI
[4]  
[Anonymous], STAT ANAL FAILURE TI
[5]   LONG-TERM OUTCOMES OF DEEP-VEIN THROMBOSIS [J].
BEYTH, RJ ;
COHEN, AM ;
LANDEFELD, CS .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (10) :1031-1037
[6]  
BRANDJES DPM, 1991, THROMB HAEMOSTASIS, V65, pA1568
[7]   THE CLINICAL COURSE OF PULMONARY-EMBOLISM [J].
CARSON, JL ;
KELLEY, MA ;
DUFF, A ;
WEG, JG ;
FULKERSON, WJ ;
PALEVSKY, HI ;
SCHWARTZ, JS ;
THOMPSON, BT ;
POPOVICH, J ;
HOBBINS, TE ;
SPERA, MA ;
ALAVI, A ;
TERRIN, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19) :1240-1245
[8]  
GJORES J E, 1956, Acta Chir Scand Suppl, V206, P1
[9]   DEEP-VEIN THROMBOSIS - A 7-YEAR FOLLOW-UP-STUDY [J].
HELDAL, M ;
SEEM, E ;
SANDSET, PM ;
ABILDGAARD, U .
JOURNAL OF INTERNAL MEDICINE, 1993, 234 (01) :71-75
[10]  
HIRSH J, 1993, HEMOSTASIS THROMBOSI, P1322